IDO1 and neoplasm: On the other hand, siIDO-mediated IDO inhibition significantly reduced Kyn production, resulting in enhanced tumor infiltration of Teff cells and the reversal of the ‘cold’ immune tumor milieu to a ‘hot’ state, thereby potentiating immune checkpoint blockade (ICB)-based treatment for ‘cold’ malignancies.